The pharmaceutical industry in India is among significant emerging markets for the global pharmaceutical industry. The Indian pharmaceutical market is expected to reach $48.5 billion by 2020. It is a seventh largest country by area and the second most populous country (with over 1.3 billion people). This is the market for our domestic sales having unlimited scope.
The range of products for domestic markets covers various therapeutic segments e.g. Anti-Malarial, Anti-Inflammatory, Antibiotics, Analgesics, Anti-Pyretics, Corticosteroids, Local Anesthetics, Anti-Coagulants, Anti-Emetic and Nutritional products. The market of Indus has a span of 250 formulations in almost every form e.g. Tablets, Capsules, Liquid Orals, Injectables (Dry & Liquid), topical solutions and ointments. The popular brands of our formulations includes Wintal, Trineurosol, Talnex, Talgesic, Calmtack, Dolocare, Prostospan, Sucroferisol, Dextrofer, Methospan, Apridex, Becobion, Buscomol